1249 related articles for article (PubMed ID: 20192716)
1. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster and postherpetic neuralgia.
Johnson RW
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
[TBL] [Abstract][Full Text] [Related]
3. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
4. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
6. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
7. Prevention of herpes zoster and its painful and debilitating complications.
Johnson R; McElhaney J; Pedalino B; Levin M
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
[TBL] [Abstract][Full Text] [Related]
8. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
Levin MJ; Schmader K
Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
[TBL] [Abstract][Full Text] [Related]
9. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
Burke MS
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
[TBL] [Abstract][Full Text] [Related]
10. Vaccination to prevent herpes zoster in older adults.
Gnann JW
J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
[TBL] [Abstract][Full Text] [Related]
11. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
Wutzler P
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
[TBL] [Abstract][Full Text] [Related]
12. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
Tyring SK; Diaz-Mitoma F; Padget LG; Nunez M; Poland G; Cassidy WM; Bundick ND; Li J; Chan IS; Stek JE; Annunziato PW;
Vaccine; 2007 Feb; 25(10):1877-83. PubMed ID: 17227688
[TBL] [Abstract][Full Text] [Related]
14. The impact of varicella zoster virus: chronic pain.
Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
[TBL] [Abstract][Full Text] [Related]
15. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
16. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
[TBL] [Abstract][Full Text] [Related]
17. A novel vaccine (Zostavax) to prevent herpes zoster.
Holcomb K; Weinberg JM
G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
[TBL] [Abstract][Full Text] [Related]
18. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
[No Abstract] [Full Text] [Related]
19. Broad-band ultraviolet B phototherapy in zoster patients may reduce the incidence and severity of postherpetic neuralgia.
Jalali MH; Ansarin H; Soltani-Arabshahi R
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):232-7. PubMed ID: 16948824
[TBL] [Abstract][Full Text] [Related]
20. [Zoster vaccine].
Wutzler P
Klin Monbl Augenheilkd; 2010 May; 227(5):384-7. PubMed ID: 20490991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
